AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced that construction of its ...
16h
HyProMag USA To Establish Early Magnet Finishing Capability as Part of Phased Texas Hub Development
Commissioning of finished magnet production equipment targeted for H1-2027, ahead of fully integrated U.S. operations ...
Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates ...
LOI establishes a framework to combine RZOLV's proprietary hydrometallurgical platform with Alkemio's molecular-recognition separation and refining technology and ...
Companies aim to improve drug discovery by training AI on one another’s data and generating large, open datasets ...
Discover how AI-powered analytics and experimental validation combine to improve target identification and accelerate drug ...
A pilot study from WuXi Biologics suggests existing fed-batch facilities could achieve an eightfold improvement in downstream ...
Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.
Lindian Resources says Australian-based ANSTO has confirmed 98% recoveries and non-radioactive mixed rare earths carbonate ...
Rare earths production is not a mining challenge, it's a processing one. We review how a host of leading developers are taking on the task.
HONG KONG SAR - Media OutReach Newswire - 1 July 2026 - L.K. Technology Holdings Limited (Stock code: 558, the "LK TECH", and together with its subsidiaries, the "Group") announces the annual results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results